Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Alopecia frontal fibrosante affects facial vellus hair and can be diagnosed with dermatoscopy.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Most patients with alopecia areata in Syria are young adult males, often with patchy scalp hair loss.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Isotretinoin can safely and effectively control acne with proper risk management and monitoring.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Quetiapine may cause hair loss.

Alopecia Areata affects both genders almost equally, mostly on the scalp, with common signs like yellow dots and exclamation mark hairs, especially in young people.

Placental stem cell exosome therapy improves hair growth and reduces hair loss.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.